Vance Thompson Vision
Sioux Falls, South Dakota, 57108, United States
NCT Number: NCT04474782
Educating patients on visual performance with presbyopic correcting intraocular lenses is crucial. Understanding the defocus curve of pre-presbyopic and emerging presbyopic crystalline lens will provide eye care provides useful information to better educate patients on visual performance expectations after cataract surgery with a presbyopic correcting intraocular lens. Our objective will be to assess the subjective range of clear vision of a pre-presbyopic and emerging presbyopic patient population utilizing a defocus curve. A comparison of the pre-presbyopic and emerging presbyopic defocus curve to all FDA-approved presbyopic intraocular lenses will be discussed in the manuscript.
Looking for future studies?
Notify Me37 year–48 year
All sexes
Observational
Sioux Falls, South Dakota, 57108, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
There is not an intervention
Time frame: Screening/enrollment visit
Vance Thompson Vision
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details